NYSE ARCA | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 6.31% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 5.55% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.08% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 5.05% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.03% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 4.95% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.93% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.84% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 4.76% |
| MNKD | MannKind Corp | Healthcare | Biotechnology | 3.38% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 3.32% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.26% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.21% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 3.11% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.1% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.06% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.9% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 2.86% |
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.